— Know what they know.
Not Investment Advice

SUNPHARMA.BO

Sun Pharmaceutical Industries Limited
1W: +0.7% 1M: +4.8% 3M: +4.3% YTD: +5.8% 1Y: +3.2% 3Y: +78.8% 5Y: +216.1%
₹1,794.85 ($19.11)
+42.05 (+2.40%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹4.31T · Alpha Radar Buy · Power 53
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹4.31T ($45.8B)
52W Range1547.25-1850.95
Volume62,505
Avg Volume127,909
Beta0.10
Dividend₹16.50
Analyst Ratings
No analyst coverage
Company Info
CEODilip Shantilal Shanghvi
Employees43,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-01-03
Sun House
Mumbai 400063
IN
91 22 4324 4324
About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms